Angola vs Armenia: Access to anti-retroviral drugs, male
Angola
52.0%
in 2024
Armenia
52.0%
in 2024
Angola rank
113th
Armenia rank
113th
Access to anti-retroviral drugs, male over time
- Angola
- Armenia
How they compare
Angola currently reports 52.0% against 52.0% in Armenia, a difference of 0.0%.
Across all 25 years both countries report, Armenia has been ahead every year.
Angola ranks 113th and Armenia ranks 113th of 141 countries.
Armenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Armenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.6% | 4.4% | 1.8% | Armenia |
| 2010s | 23.6% | 26.3% | 2.7% | Armenia |
| 2020s | 43.2% | 46.2% | 3.0% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Angola or Armenia?
- Angola, at 52.0% against 52.0% in Armenia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Angola and Armenia?
- 0.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Armenia?
- 25 years are reported by both, from 2000 to 2024.
- How do Angola and Armenia rank globally for access to anti-retroviral drugs, male?
- Angola ranks 113th and Armenia ranks 113th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.